Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Equity (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Return on Equity for 15 consecutive years, with 0.52% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 20.0% to 0.52% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.52% through Dec 2025, up 20.0% year-over-year, with the annual reading at 0.49% for FY2025, 18.0% up from the prior year.
  • Return on Equity hit 0.52% in Q4 2025 for Ironwood Pharmaceuticals, up from 0.25% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 3.2% in Q1 2024 to a low of 4.88% in Q2 2023.
  • Historically, Return on Equity has averaged 0.64% across 5 years, with a median of 0.4% in 2022.
  • Biggest five-year swings in Return on Equity: crashed -521bps in 2023 and later skyrocketed 486bps in 2024.
  • Year by year, Return on Equity stood at 0.89% in 2021, then plummeted by -57bps to 0.39% in 2022, then skyrocketed by 693bps to 3.07% in 2023, then tumbled by -90bps to 0.32% in 2024, then surged by 63bps to 0.52% in 2025.
  • Business Quant data shows Return on Equity for IRWD at 0.52% in Q4 2025, 0.25% in Q3 2025, and 0.33% in Q2 2025.